RDN at the early stage of hypertension reduced both fat mass and adipocyte size in the present study, and these changes were accompanied by the downregulation of angiotensinogen and ACE gene expression, suggesting that RDN at this stage suppressed RAS-induced adipocyte growth. This evidence concerns the gene AGT and hypertensive disorder.